NCT03567891

NCT03567891 is a clinical trial identifier for a study titled "Observational Study to Collect Real-World Data for Patients With Non-Small Cell Lung Cancer (NSCLC) in Asia." This trial aims to gather comprehensive real-world data on the treatment patterns, outcomes, and disease characteristics of patients diagnosed with non-small cell lung cancer across various Asian countries. The study design is observational, meaning that participants will receive treatment as determined by their healthcare providers, and researchers will collect data on these treatments and their effects.

The primary objectives of NCT03567891 include characterizing the current treatment landscape for NSCLC in the Asian region, assessing treatment adherence and persistence, and evaluating patient-reported outcomes and overall survival. The study will also investigate factors influencing treatment decisions and outcomes, such as patient demographics, disease stage, histology, genetic mutations, and the use of specific therapies including chemotherapy, targeted therapy, and immunotherapy.

Enrollment for this study began in 2018, and it is expected to continue for several years to capture long-term data. The participating countries are diverse, reflecting the varied healthcare systems and patient populations within Asia. The data collected from this observational study is intended to provide valuable insights for understanding NSCLC management in a real-world setting, potentially informing clinical practice guidelines and future research directions for this prevalent cancer type.